Which visual acuity measurements define high-quality care for patients with neovascular age-related macular degeneration treated with ranibizumab?

被引：0
|
作者：
A H Ross
P H J Donachie
A Sallam
I M Stratton
Q Mohamed
P H Scanlon
J N Kirkpatrick
R L Johnston
机构：
[1] Gloucestershire Hospitals,Ophthalmology Department
[2] Gloucestershire Retinal Research Group,undefined
[3] Cheltenham General Hospital,undefined
来源：
Eye | 2013年 / 27卷
关键词：
ranibizumab; visual acuity; age-related macular degeneration; neovascular;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：56 / 64
页数：8
相关论文
共 50 条
  • [1] Which visual acuity measurements define high-quality care for patients with neovascular age-related macular degeneration treated with ranibizumab?
    Ross, A. H.
    Donachie, P. H. J.
    Sallam, A.
    Stratton, I. M.
    Mohamed, Q.
    Scanlon, P. H.
    Kirkpatrick, J. N.
    Johnston, R. L.
    EYE, 2013, 27 (01) : 56 - 64
  • [2] Intravitreal Ranibizumab for Patients with Neovascular Age-Related Macular Degeneration with Good Baseline Visual Acuity
    Kato, Aki
    Yasukawa, Tsutomu
    Suga, Keiji
    Hirano, Yoshio
    Nozaki, Miho
    Yoshida, Munenori
    Ogura, Yuichiro
    OPHTHALMOLOGICA, 2015, 233 (01) : 27 - 34
  • [3] Fixation stability measurements in patients with neovascular age-related macular degeneration treated with ranibizumab
    Grenga, Pier Luigi
    Fragiotta, Serena
    Meduri, Alessandro
    Lupo, Stefano
    Marenco, Marco
    Vingolo, Enzo M.
    CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE, 2013, 48 (05): : 394 - 399
  • [4] Refractory subretinal fluid in patients with neovascular age-related macular degeneration treated with intravitreal ranibizumab: visual acuity outcome
    Liuna Jang
    Christina Gianniou
    Aude Ambresin
    Irmela Mantel
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2015, 253 : 1211 - 1216
  • [5] Refractory subretinal fluid in patients with neovascular age-related macular degeneration treated with intravitreal ranibizumab: visual acuity outcome
    Jang, Liuna
    Gianniou, Christina
    Ambresin, Aude
    Mantel, Irmela
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2015, 253 (08) : 1211 - 1216
  • [6] Visual acuity outcomes in ranibizumab-treated neovascular age-related macular degeneration; stratified by baseline vision
    Shona, Olajumoke
    Gupta, Bhaskar
    Vemala, Roopa
    Sivaprasad, Sobha
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2011, 39 (01): : 5 - 8
  • [7] Two year visual outcomes in patients with neovascular age-related macular degeneration treated with ranibizumab stratified by patient age and baseline visual acuity
    Hearne, Elewys
    Afshar, Farid
    Fletcher, Emily
    Mohamed, Quresh
    Johnston, Rob
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [8] Quality of fixation in eyes with neovascular age-related macular degeneration treated with ranibizumab
    Sivaprasad, S.
    Pearce, E.
    Chong, V.
    EYE, 2011, 25 (12) : 1612 - 1616
  • [9] Quality of fixation in eyes with neovascular age-related macular degeneration treated with ranibizumab
    S Sivaprasad
    E Pearce
    V Chong
    Eye, 2011, 25 : 1612 - 1616
  • [10] Ranibizumab for neovascular age-related macular degeneration
    Rosenfeld, Philip J.
    Brown, David M.
    Heier, Jeffrey S.
    Boyer, David S.
    Kaiser, Peter K.
    Chung, Carol Y.
    Kim, Robert Y.
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (14): : 1419 - 1431
12345